Physician profile
Ningcheng Li
NPI 1669905261
$2,888.81
in general payments reported to CMS, 2019-2025
7 companies · $17.73 in 2025
The $17.73 reported for 2025 was less than what a typical Vascular & Interventional Radiology provider received nationally (typical 2025 total: $537).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $144 · 2022: $104 · 2023: $231 · 2024: $2,392 · 2025: $17.73.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $1,873 · Food and Beverage: $768.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $1,873.49 |
| Food and Beverage | $767.73 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Penumbra, INC. | $1,906.89 | 2024 | Indigo System |
| Trisalus Life Sciences, INC. | $395.56 | 2023-2024 | Trinav Infusion System |
| Boston Scientific Corporation | $253.97 | 2023-2025 | Therasphere Y90 Glass Microspheres 10 Gbq, Embold Fibered, Eluvia |
| Abbott Laboratories | $143.65 | 2019 | |
| Inari Medical, INC. | $84.80 | 2024 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Medtronic, INC. | $82.00 | 2022 | |
| Angiodynamics, INC. | $21.94 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ningcheng Li listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.